Jaakko Tuomilehto Selected Research

Acarbose

10/2021	Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance.
1/2020	Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial.
1/2018	Global status of diabetes prevention and prospects for action: A consensus statement.
11/2017	Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
7/2014	Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial.
4/2014	On the potential of acarbose to reduce cardiovascular disease.
2/2010	Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
1/2005	Postprandial glucose regulation: new data and new implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaakko Tuomilehto Research Topics

Disease

113	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2002
41	Insulin Resistance 01/2022 - 02/2002
35	Obesity 01/2022 - 04/2004
35	Glucose Intolerance 12/2021 - 07/2003
34	Hypertension (High Blood Pressure) 09/2019 - 01/2002
31	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2002
24	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2019 - 12/2002
22	Stroke (Strokes) 12/2020 - 06/2002
19	Inflammation (Inflammations) 01/2022 - 04/2010
17	Dementia (Dementias) 03/2022 - 10/2002
17	Coronary Disease (Coronary Heart Disease) 01/2020 - 12/2002
16	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017 - 05/2002
14	Prediabetic State (Prediabetes) 12/2020 - 09/2009
12	Overweight 01/2022 - 12/2002
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2008
9	Weight Loss (Weight Reduction) 01/2021 - 01/2013
9	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2002
9	Hyperglycemia 07/2020 - 01/2005
8	Body Weight (Weight, Body) 01/2022 - 12/2003
8	Ischemic Stroke 12/2020 - 09/2005
8	Myocardial Infarction 02/2013 - 01/2004
7	Cognitive Dysfunction 01/2021 - 09/2004
7	Diabetes Mellitus 12/2020 - 01/2002
7	Abdominal Obesity 01/2018 - 06/2005
7	Isolated Systolic Hypertension 04/2012 - 10/2001
4	Fatty Liver 09/2020 - 06/2013
4	Chronic Disease (Chronic Diseases) 07/2018 - 07/2002
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 08/2012
4	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2016 - 10/2010
4	Neoplasms (Cancer) 12/2014 - 09/2011
4	Heart Valve Diseases (Valvular Heart Disease) 02/2013 - 09/2010
4	Hemorrhagic Stroke 10/2012 - 05/2009
3	Diabetes Complications 01/2019 - 01/2002
3	Ankylosing Spondylitis 05/2015 - 08/2008
3	Heart Failure 11/2013 - 01/2004
3	Hyperinsulinism (Hyperinsulinemia) 05/2010 - 05/2004
3	Alzheimer Disease (Alzheimer's Disease) 01/2009 - 01/2002
2	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

115	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2002
38	Insulin (Novolin)FDA Link 01/2022 - 12/2002
31	Antihypertensive Agents (Antihypertensives)IBA 07/2020 - 01/2002
27	CholesterolIBA 01/2019 - 01/2002
19	Triglycerides (Triacylglycerol)IBA 12/2021 - 11/2002
16	HDL CholesterolIBA 12/2019 - 05/2004
15	LipidsIBA 01/2019 - 01/2002
12	Pharmaceutical PreparationsIBA 12/2022 - 03/2003
12	Coffee FDA Link 08/2020 - 03/2004
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2010
10	LDL CholesterolIBA 09/2019 - 12/2002
8	Acarbose FDA LinkGeneric 10/2021 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2018
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2016
6	Liraglutide FDA Link 01/2022 - 02/2015
6	Blood Glucose (Blood Sugar)IBA 01/2019 - 04/2004
6	Apolipoproteins E (ApoE)IBA 01/2018 - 08/2002
6	ApolipoproteinsIBA 01/2018 - 08/2002
5	AdiponectinIBA 07/2018 - 01/2011
5	Vitamin D FDA LinkGeneric 01/2017 - 10/2004
5	HDL LipoproteinsIBA 11/2013 - 12/2008
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2002
4	UrocortinsIBA 01/2022 - 01/2019
4	C-Reactive ProteinIBA 01/2021 - 06/2009
4	oxidized low density lipoproteinIBA 09/2019 - 12/2002
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2016
4	TeaIBA 12/2017 - 11/2007
4	25-hydroxyvitamin DIBA 01/2017 - 11/2013
4	Interleukin-6 (Interleukin 6)IBA 11/2009 - 07/2003
4	AntigensIBA 08/2009 - 05/2002
4	Enalapril FDA LinkGeneric 01/2007 - 10/2001
3	NeuropeptidesIBA 01/2022 - 01/2021
3	C-PeptideIBA 01/2022 - 01/2020
3	SodiumIBA 12/2020 - 02/2002
3	Biological ProductsIBA 12/2020 - 01/2017
3	AlbuminsIBA 09/2020 - 06/2014
3	EnzymesIBA 09/2020 - 05/2010
3	GlucosidasesIBA 01/2020 - 07/2014
3	ORALIT (ORS)IBA 01/2020 - 10/2005
3	Hormones (Hormone)IBA 10/2019 - 01/2012
3	PalmitatesIBA 01/2019 - 01/2018
3	Nonesterified Fatty Acids (NEFA)IBA 01/2019 - 01/2018
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019 - 02/2013
3	CytokinesIBA 07/2018 - 07/2003
3	Dietary Fiber FDA Link 01/2018 - 12/2003
3	Lipoproteins (Lipoprotein)IBA 12/2017 - 05/2004
3	Transcription Factors (Transcription Factor)IBA 01/2017 - 04/2004
3	HLA-B Antigens (HLA-B)IBA 05/2015 - 08/2009
3	AntibodiesIBA 04/2013 - 08/2002
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 04/2012 - 10/2001
3	Indapamide FDA LinkGeneric 04/2009 - 08/2004
3	Uric Acid (Urate)IBA 03/2008 - 03/2006
3	Rosuvastatin Calcium (Crestor)FDA Link 06/2005 - 12/2002
2	Peptides (Polypeptides)IBA 01/2022 - 07/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2021 - 04/2016
2	Ferritins (Ferritin)IBA 01/2021 - 07/2018
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021 - 01/2018

Therapy/Procedure

20	Therapeutics 01/2018 - 10/2001
8	Glycemic Control 01/2019 - 01/2015
5	Injections 01/2022 - 02/2015
3	Cognitive Training 03/2022 - 06/2015
3	Diet Therapy (Therapy, Diet) 06/2007 - 01/2006